TFPI2AS1, a novel lncRNA that inhibits cell proliferation and migration in lung cancer. Issue 23 (2nd December 2017)

• Record Type: Journal Article
• Authors: Gao, Shenglan; Lin, Ziying; Li, Chunyan; Wang, Yahong; Yang, Lawei; Zou, Baoan; Chen, Jie; Li, Jianwen; Song, Zeqing; Liu, Gang
• Is Part Of: Cell cycle. Volume 16:Issue 23(2017)
• Page Start: 2249
• Page End: 2258
• Publication Date: 2017-12-02
• Subjects: lncRNA -- lung cancer -- migration -- proliferation -- TFPI2AS1; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2017.1373223
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: Accumulating evidence demonstrates that a series of differentially expressed lncRNAs is important in tumorigenesis. However, the function of many of the lncRNAs in lung cancer remains elusive. In the present study, we used microarray analysis to identify lncRNAs that are dysregulated in non-small-cell lung cancer (NSCLC) as compared with normal tissues. Among the dysregulated lncRNAs, we identified TFPI2AS1, an antisense transcript of the tumor suppressor TFPI2 (tissue factor pathway inhibitor 2). TFPI2AS1 was shown to be markedly upregulated in NSCLC patient tumors as compared to paired non-tumor samples. TFPI2AS1 knockdown increased NSCLC cell proliferation and migration, which was associated with enhanced G1/S transition and downregulation of cyclin D1 and cyclin-dependent kinases 2 (CDK2), while TFPI2AS1 overexpression had the opposite effect. Knockdown and overexpression experiments also suggested that TFPI2AS1 regulates NSCLC cell migration and AKT activation. Moreover, TFPI2AS1 is a positive regulator of TFPI2. Our findings bring new insights for understanding the role of TFPI2AS1 in mediating the proliferation and migration of NSCLC cells by regulating TFPI2 expression.